These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2956871)

  • 1. Long-term oral enoximone therapy in chronic cardiac failure.
    Maskin CS; Weber KT; Janicki JS
    Am J Cardiol; 1987 Aug; 60(5):63C-67C. PubMed ID: 2956871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enoximone (MDL 17,043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy.
    Weber KT; Janicki JS; Jain MC
    Am J Cardiol; 1986 Sep; 58(7):589-95. PubMed ID: 2944369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low dose enoximone for chronic congestive heart failure.
    Jessup M; Ulrich S; Samaha J; Helfer D
    Am J Cardiol; 1987 Aug; 60(5):80C-84C. PubMed ID: 2956875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term enoximone therapy in unstable chronic heart failure.
    Treese N; Rhein S; Erbel R; Meyer J
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S78-83. PubMed ID: 2480491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hemodynamic response to low dose enoximone (MDL 17,043): an oral dose-range study.
    Gilbert EM; Bristow MR; Mason JW
    Am J Cardiol; 1987 Aug; 60(5):57C-62C. PubMed ID: 2956870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment with oral enoximone for chronic congestive heart failure: the European experience.
    Treese N; Erbel R; Pilcher J; Choraria S; Rhein S; Dieterich HA; Meyer J
    Am J Cardiol; 1987 Aug; 60(5):85C-90C. PubMed ID: 2956876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation.
    Khalife K; Zannad F; Brunotte F; Belhadj K; Juilliere Y; Iannascoli F; Gilgenkrantz JM
    Am J Cardiol; 1987 Aug; 60(5):75C-79C. PubMed ID: 2956874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of oral long-term enoximone therapy on the arrhythmia profile in chronic heart failure].
    Treese N; Rhein S; Werneyer A; Erbel R; von Olshausen K; Pop T; Meyer J
    Z Kardiol; 1988 Oct; 77(10):653-9. PubMed ID: 2467449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
    Weber KT; Janicki JS; Jain MC
    J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic therapy of severe heart failure with enoximone.
    Gilfrich HJ; Witzke-Gross J; Römer A
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S75-7. PubMed ID: 2480490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind crossover comparison of enoximone and placebo in patients with congestive heart failure.
    Choraria SK; Taylor D; Pilcher J
    Circulation; 1987 Dec; 76(6):1307-11. PubMed ID: 2960473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure.
    Martin JL; Likoff MJ; Janicki JS; Laskey WK; Hirshfeld JW; Weber KT
    J Am Coll Cardiol; 1984 Nov; 4(5):875-83. PubMed ID: 6238075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral enoximone therapy in chronic heart failure: a placebo-controlled randomized trial. The Western Enoximone Study Group.
    Narahara KA
    Am Heart J; 1991 May; 121(5):1471-9. PubMed ID: 1826806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group.
    Uretsky BF; Jessup M; Konstam MA; Dec GW; Leier CV; Benotti J; Murali S; Herrmann HC; Sandberg JA
    Circulation; 1990 Sep; 82(3):774-80. PubMed ID: 2144216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term therapy of chronic cardiac insufficiency using enoximone].
    Treese N; Erbel R; Rhein S; Diefenbach C; Alken RG; Mohr-Kahaly S; Meyer J
    Dtsch Med Wochenschr; 1987 Jul; 112(30):1163-9. PubMed ID: 2956080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral treatment with enoximone in patients referred for cardiac transplantation.
    Coghlan JG; Norell M; Ilsley CD; Mitchell AG
    Int J Cardiol; 1991 Jul; 32(1):57-63. PubMed ID: 1830866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure.
    Shakar SF; Abraham WT; Gilbert EM; Robertson AD; Lowes BD; Zisman LS; Ferguson DA; Bristow MR
    J Am Coll Cardiol; 1998 May; 31(6):1336-40. PubMed ID: 9581729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of hemodynamic effects of one-month oral captopril and enoximone treatment for severe congestive heart failure.
    Scriven AJ; Lipkin DP; Anand IS; Sutton GC; Poole-Wilson PA
    Am J Cardiol; 1987 Aug; 60(5):68C-71C. PubMed ID: 2956872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential hemodynamic effects of oral enoximone in severe congestive heart failure.
    Murali S; Uretsky BF; Betschart AR; Tokarczyk TR; Kolesar JA; Reddy PS
    Am J Cardiol; 1990 Feb; 65(7):515-9. PubMed ID: 2137668
    [No Abstract]   [Full Text] [Related]  

  • 20. A dose-response study of intravenous enoximone in congestive heart failure.
    Erbel R; Meyer J; Diefenbach C; Delorme G; Bourdarias JP; Vernant P; Lellouche D; Mattioli G; Barbieri A; Installe E
    Am J Cardiol; 1987 Aug; 60(5):31C-36C. PubMed ID: 2956865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.